Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

With Huge Debts And Divestment Plans, Wockhardt Chairman Habil Khorakiwala Exhorts Employees To Rise To The Challenge

This article was originally published in PharmAsia News

Executive Summary

MUMBAI - These are tough times for Habil Khorakiwala, chairman of Wockhardt, one of India's largest pharmaceutical and biotechnology companies, as he deals with the worst financial crisis that any large Indian drug company has faced in the aftermath of the global economic meltdown
Advertisement

Related Content

Brakes May Be Put On Direct MNC Deals In India As Government Fears Threat To The Indian Drug Industry
Brakes May Be Put On Direct MNC Deals In India As Government Fears Threat To The Indian Drug Industry
Buzz Of Bids By GSK, Sanofi And Merck Get Louder As Piramal, Wockhardt Decline Sell-Off Talks
Buzz Of Bids By GSK, Sanofi And Merck Get Louder As Piramal, Wockhardt Decline Sell-Off Talks
Advertisement
UsernamePublicRestriction

Register

SC071536

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel